TWD
ARCT icon

True Wealth Design’s Arcturus Therapeutics ARCT Stock Holding History

True Wealth Design’s Portfolio ARCT Stock Details ARCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$3.53K Buy
258
+5
+2% +$52 ﹤0.01% 1467
2026
Q2 		$1.7K Buy
253
+192
+315% +$1.51K ﹤0.01% 1759
2026
Q1 		$471 Buy
61
+56
+1,120% +$409 ﹤0.01% 2078
2025
Q4 		$31 Buy
+5
New +$54 ﹤0.01% 2460

Other funds holding ARCT

HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return
GAA
Green Alpha Advisors Niwot, Colorado $148M AUM 98.22% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
EP
Essential Partners Rancho Santa Fe, California $219M AUM 37.92% 1-Year Est. Return
FFO
Fortitude Family Office Scottsdale, Arizona $586M AUM 20.58% 1-Year Est. Return
MAM
Marquette Asset Management Minneapolis, Minnesota $766M AUM 16.04% 1-Year Est. Return

True Wealth Design's ARCT Position: Q3 2026 in Review

True Wealth Design increased its Arcturus Therapeutics (ARCT) stake by 2% in Q3 2026, buying an estimated $52 and bringing the position to 258 shares worth $3.53K. The position accounts for ﹤0.01% of the portfolio, ranked #1467.

True Wealth Design first reported a position in ARCT in Q4 2025 and has held it in 4 quarters since. 10 funds tracked by Wall St. Rank hold ARCT as of Q3 2026.

  • True Wealth Design held 258 shares of Arcturus Therapeutics worth $3.53K as of Q3 2026.
  • True Wealth Design bought 5 Arcturus Therapeutics shares in Q3 2026, an estimated $52.
  • Arcturus Therapeutics made up ﹤0.01% of True Wealth Design's portfolio in Q3 2026, its #1467 holding.
  • True Wealth Design first reported a position in Arcturus Therapeutics in Q4 2025 and has held it in 4 quarters since.
  • 10 funds tracked by Wall St. Rank held Arcturus Therapeutics as of Q3 2026.

Based on True Wealth Design's 13F filing for Q3 2026, filed 13 Oct 2026.